Patent · US Active

Cell penetrating peptides

US9657064B2 · kind B2 · utility

6Cited by
2References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 12, 2013
Grant dateMay 23, 2017
Priority date
Expiry dateSep 12, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/18522
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a short cell penetrating peptide derived from the Epstein-Barr virus basic leucine zipper transcriptional activator (ZEBRA), optionally linked to a cargo molecule. It also relates to a complex comprising the cell penetrating peptide and a cargo molecule, as well as cells loaded with the complex and the use thereof in therapy and diagnosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.